ENZYME-LINKED IMMUNOSORBENT-ASSAY OF VENOM-ANTIBODIES IN HUMAN VICTIMS OF SNAKE BITE
- 1 January 1981
- journal article
- research article
- Vol. 84 (3) , 109-112
Abstract
The development, incidence, persistence and significance of specific venom-antibodies were studied in 357 human victims of snake bite in Nigeria using the enzyme-linked immunosorbent assay (ELISA). Venom-antibody was not detected within 2 wk of envenoming but was present within 2 mo. of the bite despite therapeutic antivenom being given. ELISA confirmed the medical importance of the carpet viper Echis carinatus in Nigeria, but showed that bites by other venomous species are more common than previously suspected. Venom-antibodies may wane with time, but were still present 40 yr after the original envenoming. Clinical studies suggested that venom-antibody titers too low to be detected by ELISA may be boosted with further bites; and more importantly, homologous venom-antibody may afford significant protection against further envenoming. ELISA can help both in advancing the epidemiology of snake bite and in exploring the role of active immunization.This publication has 3 references indexed in Scilit:
- INCIDENCE AND MORTALITY OF SNAKE BITE IN SAVANNA NIGERIAThe Lancet, 1980
- Malumfashi Endemic Diseases Research Project, XIIIPathogens and Global Health, 1980
- MICRO-ELISA FOR DETECTING AND ASSAYING SNAKE VENOM AND VENOM-ANTIBODYThe Lancet, 1977